| Molecular bases of the poor response of liver cancer to chemotherapy |
16 |
| Characteristics and prevalence of Wilson's disease: A 2013 observational population-based study in France |
11 |
| Wilson's disease: A 2017 update |
11 |
| Meta-analysis of the association between MBOAT7 rs64 TM6SF2 rs58542926 and nonalcoholic fatty liver disease |
10 |
| Polymorphism in the promoter region of lncRNA GAS5 is functionally associated with the risk of gastric cancer |
10 |
| Long non-coding RNA LINC00472 suppresses hepatocellular carcinoma cell proliferation, migration and invasion through miR-93-5p/PDCD4 pathway |
9 |
| The role of ROS-induced autophagy in hepatocellular carcinoma |
9 |
| Increased mortality in non-alcoholic fatty liver disease with chronic kidney disease is explained by metabolic comorbidities |
8 |
| Animal models of cholangiocarcinoma: What they teach us about the human disease |
7 |
| Primary sclerosing cholangitis response to the combination of fibrates with ursodeoxycholic acid: French-Spanish experience |
7 |
| Non-alcoholic fatty liver disease in non-obese individuals: Prevalence, pathogenesis and treatment |
7 |
| Gut microbiota and hypertension: From pathogenesis to new therapeutic strategies |
7 |
| Non-alcoholic fatty liver disease causes dissociated changes in metabolic liver functions |
7 |
| MicroRNA-101 suppresses liver fibrosis by downregulating PI3K/Akt/mTOR signaling pathway |
7 |
| Systematic review of progressive familial intrahepatic cholestasis |
7 |
| Portal vein thrombosis and liver cirrhosis: Long-term anticoagulation is effective and safe |
6 |
| Hepatoprotective effects of ethyl pyruvate against CCl4-induced hepatic fibrosis via inhibition of TLR4/NF-kappa B signaling and up-regulation of MMPs/TIMPs ratio |
6 |
| Physical exercise in cirrhotic patients: Towards prehabilitation on waiting list for liver transplantation. A systematic review and meta-analysis |
6 |
| CDKN2A promoter methylation and hepatocellular carcinoma risk: A meta-analysis |
6 |
| Individuals affected by eosinophilic gastrointestinal disorders have complex unmet needs and frequently experience unique barriers to care |
6 |
| Life expectancy in pancreatic neuroendocrine cancer |
5 |
| Epidemiology of Budd-Chiari syndrome: A systematic review and meta-analysis |
5 |
| Diagnosis of local hepatic tuberculosis through next-generation sequencing: Smarter, faster and better |
5 |
| Features and outcomes from a retrospective study of 570 hospitalized Chinese patients with drug-induced liver injury |
5 |
| Treatment with mTOR inhibitors after liver transplantation enables a sustained increase in regulatory T-cells while preserving their suppressive capacity |
5 |
| Serum anti-TOPO48 autoantibody as a biomarker for early diagnosis and prognosis in patients with esophageal squamous cell carcinoma |
5 |
| Risk of metachronous advanced lesions after resection of diminutive and small, non-advanced adenomas |
5 |
| Direct-acting antiviral therapy enhances total CD4+and CD8+T-cells responses, but does not alter T-cells activation among HCV mono-infected, and HCV/HIV-1 co-infected patients |
5 |
| Recent developments in the research on biomarkers of cholangiocarcinoma in primary sclerosing cholangitis |
4 |
| The early prognostic value of inflammatory markers in patients with acute pancreatitis |
4 |
| Quality of life in 1870 patients with constipation and/or fecal incontinence: Constipation should not be underestimated |
4 |
| Hydrogen-rich water reduces liver fat accumulation and improves liver enzyme profiles in patients with non-alcoholic fatty liver disease: a randomized controlled pilot trial |
4 |
| An update on the physiopathology and therapeutic management of cholestatic pruritus in children |
4 |
| Soluble epoxide hydrolase inhibition with t-TUCB alleviates liver fibrosis and portal pressure in carbon tetrachloride-induced cirrhosis in rats |
4 |
| Incidence and characteristics of young-onset colorectal cancer in the United States: An analysis of SEER data collected from 1988 to 2013 |
4 |
| Hepatitis E virus infection mimicking acute graft rejection in a liver transplant recipient |
4 |
| Microvascular invasion and positive HB e antigen are associated with poorer survival after hepatectomy of early hepatocellular carcinoma: A retrospective cohort study |
4 |
| Helicobacter pylori infection aggravates diet-induced nonalcoholic fatty liver in mice |
4 |
| Snapshot summary of diagnosis and management of hepatocellular adenoma subtypes |
4 |
| Co-expression of PDGF-B and VEGFR-3 strongly correlates with poor prognosis in hepatocellular carcinoma patients after hepatectomy |
4 |
| Assessment of liver fibrosis by transient elastography (Fibroscan (R)) in patients with A1AT deficiency |
4 |
| Health-related quality of life in pre-adolescent liver transplant recipients with biliary atresia: A cross-sectional study |
4 |
| A long-term multicenter study: Entecavir versus Tenofovir in treatment of nucleos(t)ide analogue-naive chronic hepatitis B patients |
4 |
| Clinical significance of C/D box small nucleolar RNA U76 as an oncogene and a prognostic biomarker in hepatocellular carcinoma |
4 |
| Performance of spleen stiffness measurement in prediction of clinical significant portal hypertension: A meta-analysis |
4 |
| Surgical outcomes between patients with and without a cirrhotic liver undergoing laparoscopic liver resection: A meta-analysis |
4 |
| A changing etiologic scenario in liver transplantation for hepatocellular carcinoma in a multicenter cohort study from Latin America |
4 |
| Patient-reported tolerance in treatments approved in neuroendocrine tumors: A national survey from the French Group of Endocrine Tumors |
3 |
| Role of vitamin D deficiency as a risk factor for infections in cirrhotic patients |
3 |
| Efficacy of ombitasvir/paritaprevir/ritonavir/ribavirin in management of HCV genotype 4 and end-stage kidney disease |
3 |
